selected publications
-
COVID-19 in patients with lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology.
2020
Academic Article
GET IT
Times cited: 152 -
Quest for Clinically Effective RAF Dimer Inhibitors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 5 -
A treatment strategy for KRAS-driven tumors.
Nature medicine.
2018
Comment
GET IT
Times cited: 21 -
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2017
Academic Article
GET IT
Times cited: 236 -
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
Nature medicine.
2017
Academic Article
GET IT
Times cited: 107 - Predicting MEK Inhibitor Response in Lung Cancer: A Proper Signature Is Required. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
-
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Clinical lung cancer.
2016
Academic Article
GET IT
Times cited: 100 -
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.
Science (New York, N.Y.).
2016
Academic Article
GET IT
Times cited: 422 -
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
Science translational medicine.
2014
Academic Article
GET IT
Times cited: 98 -
Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors.
Cancer cell.
2014
Academic Article
GET IT
Times cited: 203 -
Tumor adaptation and resistance to RAF inhibitors.
Nature medicine.
2013
Review
GET IT
Times cited: 430 -
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas.
Cancer cell.
2012
Academic Article
GET IT
Times cited: 397 -
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic series.
The American journal of the medical sciences.
2009
Academic Article
GET IT
Times cited: 10 -
Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblasts.
The Journal of biological chemistry.
2008
Academic Article
GET IT
Times cited: 19 -
Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
The Journal of biological chemistry.
2007
Academic Article
GET IT
Times cited: 31